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Introduction
Bone morphogenetic proteins (BMPs) are members of the
transforming growth factor (TGFβ) superfamily of secreted
ligands that fulfil multiple functions during the development of
vertebrate as well as non-vertebrate species (Hogan et al.,
1996). Specific heteromeric type I/type II serine/threonine
kinase receptor complexes mediate BMP action. Type I
receptors, also termed ALKs (activin-receptor-like kinase) act
downstream of type II receptors and determine the specificity
within the receptor complex. The type I receptors, in turn,
activate their intracellular downstream targets, known as
Smads (Heldin et al., 1997). Smad proteins can be subdivided
into three categories: receptor-regulated Smads (R-Smads),
which transiently interact with type I receptors and become
phosphorylated at their C-terminal motif SSXS; common
partner Smads (Co-Smads), which associate with R-Smads and
translocate them to the nucleus and modulate transcription of
target genes; and inhibitory Smads (I-Smads), which can
interfere with TGFβ/Activin/BMP signaling by binding to
activated R-Smad proteins or targeting type I receptors for
degradation (Chang et al., 2002). TGFβ (via type I receptor
ALK5) and activin (via type I receptor ALK4) signaling is
mediated by R-Smads 2 and 3, while BMP-dependent
signaling (via type I receptors ALK2, ALK3 and ALK6) is
mediated specifically by R-Smads 1, 5 and 8 (Derynck and
Zhang, 2003; ten Dijke et al., 2003). Activation of Smad1 and
Smad5 by BMPs has been described in endothelial cells
(Valdimarsdottir et al., 2002), although TGFβ can also activate
Smads 1 and 5 through ALK1 in these cells (Goumans et al.,
2002). The Smad complexes recognize specific sequences in
the promoters of target genes that, in combination with co-
factors, effectively determine the transcriptional regulation of
target genes (Hata et al., 2000; Zwijsen et al., 2003). Recently,
a number of short promoter sequences have been identified
that, when multimerized, can elicit transcription of reporter
genes in response to TGFβ superfamily ligands. TGFβ, activin
and BMP activate transcription of a luciferase reporter, driven
by Smad-binding elements (SBE) derived from the c-jun
promoter (Jonk et al., 1998), while SBE sequences derived
from the PAI-1 promoter are responsive to ALK5 and ALK4,
but not ALK1-, ALK2-, ALK3- or ALK6-mediated signaling
(Dennler et al., 1998). Similar sequences (including SBEs)
were found in the promoter of Id1 (inhibitor of differentiation
1), a BMP target gene (Hollnagel et al., 1999; Korchynskyi and
ten Dijke, 2002), and shown to be responsive to BMP, but not
to TGFβ or activin in C2C12 myoblasts (Katagiri et al., 2002;
Korchynskyi and ten Dijke, 2002; Lopez-Rovira et al., 2002).
Examination of BMP ligand, receptor and Smad expression
and the effects of gene ablation in mice have demonstrated that
BMP signaling is essential in many developmental processes
(Jones et al., 1991; Dick et al., 1998; Flanders et al., 2001).
Mice lacking BMP4, the BMP type II receptor (BmpRII) or
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Signaling by bone morphogenetic proteins is essential for
a wide variety of developmental processes. Receptor-
regulated Smad proteins, Smads 1 and 5, are intracellular
mediators of bone morphogenetic protein signaling.
Together with Smad4, these proteins translocate to the
nucleus and modulate transcription by binding to specific
sequences on the promoters of target genes. We sought to
map transcriptional Smad1/5 activity in development by
generating embryonic stem cell lines carrying a Smad1/5-
specific response element derived from the Id1 promoter
coupled to β-galactosidase or luciferase as reporters. Three
independent lines (BRE-lac1, BRE-lac2 and BRE-luc) have
shown the existence of an autocrine bone morphogenetic
protein signaling pathway in mouse embryonic stem cells.
Reporter activity was detected in chimeric embryos,
suggesting sensitivity to physiological concentrations of
bone morphogenetic protein. Reporter activity in embryos
from transgenic mouse lines was detected in tissues where
an essential role for active bone morphogenetic protein
signaling via Smads 1 or 5 had been previously established.
We have thus generated, for the first time, an in vivo
readout for studying the role of Smad1/5-mediated
transcriptional activity in development.
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the type I receptor BmpRIa (ALK3) show defects in mesoderm
differentiation or fail to initiate gastrulation (reviewed in
Chang et al., 2002). BMP4 and BMP8b were shown to be
necessary for allocation of cells to the germline, because
homozygous null mutants for these genes have no primordial
germ cells (PGCs) (Lawson et al., 1999; Ying et al., 2000).
Deletion of Smad1 in mice results in defective extra-embryonic
development, reduced numbers of PGCs and embryonic
lethality around embryonic day 10.5 (E10.5) (Hayashi et al.,
2002; Lechleider et al., 2001; Tremblay et al., 2001). BMP2 is
essential for heart formation: BMP2 knockout mice lack or
have retarded or malformed hearts (Zhang and Bradley, 1996).
Both BMP4 and Smad5 null mice show defects in heart looping
(Chang et al., 1999; Chang et al., 2000; Fujiwara et al., 2002).
Tissue-specific deletion of ALK3 in cardiomyocytes, which
circumvents early lethality, has shown that signaling by BMPs
via ALK3 in these cells is essential for atrioventricular cushion
formation and septal morphogenesis, although no defects were
observed in the outflow tract (Delot, 2003; Gaussin et al.,
2002). Interestingly, mice carrying a hypomorphic allele of the
BmpRII lack septation in the outflow tract, but have no other
heart defects (Delot et al., 2003). BMPs are also involved in
limb and bone development, as well as in formation of teeth
and whisker follicles (Dick et al., 1998; Dudley and Robertson,
1997; Flanders et al., 2001; Hogan, 1996; Jones et al., 1991;
Lyons et al., 1995).
It is, however, important to realize that the response to BMPs
depends not only on the availability of ligands but also on the
presence of appropriate receptor combinations, extracellular
antagonists such as noggin, chordin or follistatin (Balemans
and Van Hul, 2002) and intracellular inhibitors, such as I-
Smads (Chang et al., 2002). Availability of specific co-
activators and co-repressors in different tissues also modulate
the transcriptional response to BMPs mediated by Smad1/5/8
(Zwijsen et al., 2003). The outcome of this complex interplay
reflects the actual transcriptional activity elicited by BMP
signaling via Smads1, 5 and 8. To map active Smad1/5
transcriptional activity throughout development, we designed
constructs harboring the BMP-responsive element (BRE)
identified previously in the Id1 promoter (Korchynskyi and ten
Dijke, 2002) and used them to generate transgenic reporter
mice. We used mouse embryonic stem (ES) cells to select
clones with the highest response to BMP in vitro for blastocyst
injection to optimize the chances of generating mice reporting
net transcriptional activity mediated by Smad1/5 proteins, in
vivo. Of the three ES reporter cell lines selected, two expressed
β-galactosidase (BRE-lac1 and BRE-lac2) and one expressed
luciferase (BRE-luc) under the control of the BRE, here
referred to collectively as Smad1/5 reporter ES cell lines.
These ES lines all showed an autocrine BMP-activated signal
transduction pathway while undifferentiated. In addition, the
BRE-β-galactosidase transgenic mouse lines established from
these cells showed reporter expression patterns that mapped to
sites previously associated with active Smad1/5 signaling.
Transgenic mice are now available that report Smad1- and
Smad5-dependent transcriptional activity in vivo.
Materials and Methods
Generation of reporter constructs
The BMP-responsive construct BRE-luc has been described
previously (Korchynskyi and ten Dijke, 2002). To generate the BRE-
β-galactosidase construct, an NcoI/BamHI fragment containing the
luciferase coding sequence of the BRE-luc was replaced by a
NcoI/BamHI fragment from PSDKlacZpA (gift from T. Oosterveen)
containing the β-galactosidase sequence and a poly(A) sequence.
Generation of reporter ES cells
IB10 ES cells, a subclone of E14 cells, were co-electroporated with
DraIII linearized BRE-luc or XmnI linearized BRE-β-galactosidase
reporter and a XhoΙ linearized PGK-hygromycin resistance cassette
(te Riele et al., 1990). Electroporation conditions are described
elsewhere (Goumans et al., 1998). After 8 days in culture in the
presence of hygromycin (150 µg/ml), single resistant colonies were
picked and DNA isolated for genotyping by PCR using primers
5′ CCTTTCGCTATTACGCCAG 3′ (sense) and 5′ TTAAG-
TTGGGTAACGCCAGG 3′ (antisense) for the BRE-β galactosidase
construct and 5′ CACACAGTTCGCCTCTTTGA 3′ (sense) and
5′ AAGATGTTGGGGTGTTGGAG 3′ (antisense) for the BRE-
luciferase construct. Based on the response to 5 ng/ml of BMP4 (R&D
systems), two independent β-galactosidase reporters (BRE-lac1 and
BRE-lac2) and one luciferase reporter line (BRE-luc) were selected
for further characterization.
Cell culture, transient transfections and western blots
ES cells were routinely cultured on a monolayer of irradiated primary
mouse embryonic fibroblasts in complete medium (CM): GMEM
(BHK-21, Invitrogen) supplemented with 2 mM L-glutamine, 100
mM sodium pyruvate, non-essential amino acids (1:100, Invitrogen),
10% fetal calf serum (FCS), Leukemia inhibitory factor (LIF, 103
U/ml) and 0.1 mM β-mercaptoethanol. Alternatively, ES cells were
cultured in the absence of feeder cells in BRL-conditioned medium
[BRL CM: DMEM medium conditioned in Buffalo rat liver cells,
supplemented with 2 mM L-glutamine and non-essential aminoacids
(1:100) and 20% FCS] as described previously (Mummery et al.,
1990). HepG2, C2C12 and MDA MB468 cells were cultured in
DMEM supplemented with 10% FCS. For transfection, HepG2,
C2C12 and MDA MB468 cells were seeded at 1.5× 04 cells/cm2 in
12-well plates, grown overnight (o/n) then transiently transfected with
the BRE-luc reporter (150 ng/well; 300 ng/well for HepG2) in the
absence or presence of expression plasmids (150 ng/well each one).
pcDNA3 plasmid was used to keep the total amount of transfected
DNA constant (500 ng of total plasmid DNA/well, 1 µg for HepG2
cells). Transfections were carried out using FuGene6 transfection
reagent (Roche) following the manufacturer’s protocol. β-
Galactosidase plasmid co-transfection (50 ng/well) was used as an
internal control to normalize transfection efficiency. 16 hours before
lysis, cells were exposed to growth factors (BMP2, 4, 6, 7, or TGFβ1;
EGF and FGF, purchased from Peprotech, USA) at concentrations
indicated in the figures. Luciferase and β-galactosidase activity were
quantified using the Luciferase assay (Promega) with Victor
luminometer (Wallac) as described previously (Jonk et al., 1998).
Cultures were maintained in a humidified chamber in a 5% CO2/air
mixture at 37°C.
To investigate the response of the Smad1/5 reporter lines to BMP
or noggin, these ES cells were cultured in BRL CM in the absence of
feeders, supplemented with 0.1 mM β-mercaptoethanol and either
20% or 5% FCS. On day 1, 2.5×104 cells/cm2 were seeded in
gelatinized 12-well plates and allowed to grow for 24 hours. On day
2, cells were washed once with phosphate buffered saline (PBS) and
fresh BRL CM supplemented with 5% FCS and BMP4 and noggin
(R&D systems) was added. On day 3, BRE-lac1 and BRE-lac2 ES
cells were lysed with 100 µl of RIPA buffer (150 mM NaCl, 50 mM
Tris-HCl pH 8, 1% NP-40, 0.5% deoxycholate, 2 mM EDTA, 25 mM
β-glycerophosphate, 1 mM Na3VO4, 100 mM NaF and 20 µg/ml
aprotinin, 40 µg/ml leupeptin, 0.75 mM PMSF) and BRE-luc ES cells
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with 200 µl of luciferase lysis buffer (25 mM glycylglycin, 15 mM
MgSO4, 4 mM EDTA, 1% Triton X-100). Reporter activity was
measured in 10 µl and 50 µl of whole cell lysates for β-galactosidase
and luciferase, respectively. β-Galactosidase activity was measured
with the Galacto Plus kit (AB systems) and luciferase with Luclite
substrate (Perkin-Elmer) in a luminometer (Packard), following the
manufacturer’s instructions. Western blot with an antibody raised
against the phosphorylated C-terminal peptide SSVS of Smads 1,
5 and 8 (PSmad1/5/8), PS1 (Persson et al., 1998) and anti-Id1
(Santacruz Biotechnology, 1:500 dilution) was performed on BRE-
lac1 and BRE-lac2 ES cell lysates essentially as described (Faure et
al., 2000). BCA protein assay kit (PIERCE Biotechnology) was used
for protein quantification. 10 µg total protein was loaded in each lane.
Both PSmad1/5/8 and Id1 proteins were probed in the same blot; each
experiment was repeated at least twice.
Genomic DNA isolation, RNA isolation, cDNA synthesis and
PCR
Genomic DNA was isolated using standard techniques (Sambrook et
al., 1989). RNA was isolated with Ultraspec (Biotecx) following
manufacturer’s instructions and subjected to DNase treatment. 1 µg
of total RNA was used to synthetize cDNA with M-MLV-RT
(Superscript, Isogen). 1/20 of the cDNA was used for PCR. When
appropriate, RNA was used as negative control. PCR conditions were
as follows: after 5 minutes of denaturation at 94°C, 40 amplification
cycles were performed, each including denaturation at 94°C, 15
seconds, annealing at 30 seconds at the primer’s specific temperature
(see below) and 45 seconds extension at 72°C. These cycles were
followed by a 7 minutes extension at 72°C. Samples were analyzed
on 2% agarose gels. Primers for the following genes were used for
RT-PCR: BMP2, BMP4, BMP7 (60°C annealing temperature),
described elsewhere (Roelen et al., 1997), Oct4 (55°C annealing)
(Levenberg et al., 2002) and β-actin (56°C annealing) (Roelen et al.,
1997).
Generation of teratomas
Teratomas were generated by injecting approximately 5×104 ES cells
(in PBS) in the testis capsule of 129/Ola mice. Briefly, ES growing
on feeders were washed with PBS, trypsinized, resuspended in CM
medium, seeded in gelatinized wells and allowed to recover for 1 hour
at 37°C. Attached ES cells were resuspended in CM medium, counted,
centrifuged and resuspended in PBS (150-200 µl). Following
injection, mice were monitored weekly for swelling and signs of
discomfort. At 4 weeks after injection, teratomas were isolated in PBS
and fixed in 4% paraformaldehyde (PFA) for 2-4 hours at 4°C and
stained overnight with X-Gal for β-galactosidase activity. After
washing with PBS, teratomas were post-fixed in 4% PFA overnight at
4°C, dehydrated and embedded in paraffin. 7 µm sections were stained
with Haematoxylin and Eosin or with Neutral Red and mounted in
DEPEX.
Chimeric embryos and transgenic mice
BRE-lac1, BRE-lac2 or BRE-luc ES reporter cells were injected into
the inner cell mass of C57BL/6 blastocysts. These were implanted in
pseudopregnant C57BL/6xCBA recipients and allowed to develop to
term. Male chimeras were crossed with C57BL/6xCBA females and
the F1 progeny genotyped for germline transmission of the transgene.
To generate chimeric embryos for analysis, BRE-lac1 ES cells were
injected into GFP-expressing blastocysts (Hadjantonakis et al., 1998),
which were implanted in pseudopregnant C57BL/6xCBA recipients
and allowed to develop until E9.5. Noon of the day of the vaginal plug
is E0.5.
BRE-lac1 and BRE-lac2 F1 transgenic males were crossed with
C57BL/6xCBA females to obtain transgenic embryos at E9.5.
Chimeric and transgenic embryos were isolated in ice-cold PBS, fixed
in 0.4% PFA for 30 minutes at 4°C and stained overnight with X-Gal.
All animal experiments were in abidance with Dutch Law.
β-galactosidase staining and immunohistochemistry
Before staining, ES cells were fixed briefly with 0.1% glutaraldehyde,
0.5% formaldehyde in PBS, followed by three washes with PBS.
Samples were stained for 2 hours to o/n at 30°C in X-gal staining
solution (200 mM X-gal, 5 mM K3Fe(CN)6, 5 mM K4Fe(CN)6, 1 mM
MgCl2 in PBS). After staining, samples were washed three times with
PBS and post-fixed for 30 minutes with 2% PFA at room temperature.
Embryos were isolated in ice cold PBS, fixed in 0.4% PFA in PBS
and stained for β-galactosidase o/n at 30°C in X-gal staining solution,
as described (Nagy et al., 2003). After staining, the embryos were
washed in PBS, fixed o/n in 4% PFA at 4°C, dehydrated and
embedded in plastic or paraffin. Serial sections of 6 µm were cut and
counterstained with Neutral Red or with Haematoxylin. For anti-
PSmad1/5/8 antibody (PS1) staining, paraffin sections of X-gal
stained E9.5 transgenic embryos were rehydrated, treated with 1.2%
hydrogen peroxide for 15 minutes and boiled in 10 mM Tris, 1 mM
EDTA, pH9 for 20 minutes for antigen retrieval. After washing with
PBS, sections were blocked with 0.05% BSA in PBS for 30 minutes
and incubated with PS1 (Cell Signaling) 1:200 in blocking solution,
o/n at 4°C. After o/n incubation, PowerVision™ Poly-HRP-
Conjugates (ImmunoVision Technologies) was used as secondary
antibody with the Fast 3,3′-diaminobenzidine tablet set (DAB,
SIGMA).
Whole mount photomicrographs were taken on a Camedia C3030
digital camera mounted on an Olympus SZX9 microscope. Sections
were photographed with a Nikon DMX1200 digital camera on a
Nikon eclipse E600 microscope and in a MC100 Spot camera
mounted on a ZEISS axioplan microscope.
Results
Specific activation of the BMP response element by
Smad1/4 and Smad5/4 complexes
We used BMP-responsive elements (BRE) recently identified
within the promoter of Id1 (Katagiri et al., 2002; Korchynskyi
and ten Dijke, 2002; Lopez-Rovira et al., 2002) to generate
reporter BRE-β-galactosidase and BRE-luciferase constructs
(Fig. 1A). In C2C12 cells, addition of BMP2, 4, 6 or 7
increases the reporter activity, while addition of TGFβ1,
epidermal growth factor (EGF) or fibroblast growth factor
(FGF) had no effect (Fig. 1B). Activin also had no effect on
reporter activity (Korchynskyi and ten Dijke, 2002). This
showed that only BMPs specifically activated the BRE-
luciferase reporter in these cells. We showed previously that
co-operation between Smad1/5 and Smad4 and presence of
both of their putative binding sites in the BMP target gene
promoters is critically important for transcriptional activation
of those genes (Korchynskyi and ten Dijke, 2002). Over-
expression of Smad1 or Smad5 led to a highly significant
increase of the BRE-luciferase reporter activity in C2C12 cells;
Smad8 induced only a marginal increase (Fig. 1C). In all cases,
however, reporter activity was increased upon addition of
BMP6 (Fig. 1C). Co-transfection of Smad1 and Smad4 or
Smad5 and Smad4 led to upregulation of the reporter activity
in C2C12 cells (Fig. 1D), indicating that the combination of
one R-Smad (Smad1 or Smad5) with Smad4 is sufficient for
an efficient transcriptional activation of the reporter in the
absence of ligand. The combination Smad8 and Smad4 was
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effective although much less efficient than Smad1+4 or
Smad5+4 (4-fold compared with 60-90-fold, results not
shown). Smad4 alone did not activate the BRE-luciferase
reporter. Furthermore, addition of BMP6 showed lower
induction of reporter when Smad4 was co-transfected
compared with the control, suggesting that Smad4 is necessary,
and that Smad1 or Smad5 are also required for efficient
induction of the reporter activity. Interestingly, co-transfection
of Smad1+4 was more efficient in activating the reporter than
Smad5+Smad4 (Fig. 1D) whereas the additive effect on
reporter activity observed after addition of BMP6 was similar
for Smad1+4 and Smad5+4 combinations. In the light of the
marginal response to Smad8 (2-fold) compared with induction
by Smad1 or 5 (7-10 fold, see Fig. 1C), the BRE promoter is
regarded predominantly as a Smad1/5 reporter and will be
further referred to as such.
To explore whether intrinsic Smad4 DNA-binding activity is
critically important to drive the BMP response, we used a
Smad4-deficient cell line, MDA MB468. Wild-type Smad4,
but not Smad4-D4, a DNA-binding-deficient mutant
containing mutations K81R and R88K in the Smad4 DNA-
binding domain (Moren et al., 2000), rescued inducibility of
BRE-Luc reporter by BMP-6 in this cell line when co-
transfected with Smad1 or Smad5 (Fig. 1E). Similar results
were obtained by using single mutants, either K81R or R88K
(results not shown).
Constitutively active type I receptors (caALKs) can activate
specific downstream Smad proteins, mimicking the effect of
ligand addition (Wieser et al., 1995). Because we showed that
Smad1+4 and Smad5+4 complexes are critical for activation
of the BRE-luciferase reporter, we expected it to be
upregulated by type I receptors that specifically activate Smad1
and Smad5 (ALK1, ALK2, ALK3 and ALK6) but not
receptors that activate Smad2 or Smad3 (ALK5 and ALK4)
signaling. To test this hypothesis, we co-transfected caALK1
to 6 with the BRE-luciferase reporter in HepG2 cells. As
expected, the BRE-luciferase reporter was specifically
activated by caALK1, 2, 3 and 6, but not by caALK4 or
caALK5 (Fig. 1F). Taken together, these results show that
pecific transcriptional activation of the BRE-luciferase
r porter requires DNA binding of Smad1+4 or Smad5+4
complexes. These complexes bind to the BRE element after
activation of Smad1/5 proteins by type I receptors ALK1,
ALK2, ALK3 and ALK6 and are able to induce the expression
of target genes.
Transient transfection of the BRE-luciferase reporter
construct in ES cells showed specific activation by BMP4 and
by caALK3. Co-transfection of either Smad7 or Smad6
blocked basal and BMP-induced reporter activity (Fig. 1G and
results not shown, respectively). A BRE element containing
GGCGCC and CAGC motifs, but lacking SBE-binding sites
(2C2P2C-luc, see Fig. 1A) failed to respond to stimulation by
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Fig. 1.Specificity of the BMP response element
(BRE) to Smad1/5-mediated BMP signaling in
vitro. (A) The BRE sequence consists of two
repeats of 2×SBE (bold), 1×CGCC (underlined),
2×CAGC (bold, italic) and 1×GGCGCC (double
underlined). 2C2P2C is a similar sequence that
lacks 2×SBE + 1×CGCC binding sites and does
not respond to BMPs in vitro (see Korchynskyi
and ten Dijke, 2002). (B) In C2C12 cells, the
BRE-luc reporter is specifically upregulated by
BMP2, 4, 6 and 7 (100 ng/ml). 10 ng/ml of
TGFβ, EGF or FGF do not activate reporter
transcription. (C) BRE-luc reporter activity is
induced by overexpression of either Smad1 or
Smad5 and to a lower extent, by Smad8 in
C2C12 cells. BRE-luc reporter activity is further
increased upon addition of BMP6 to control cells
or cells overexpressing Smad1, 5 or 8.
(D) Overexpression of Smad1+Smad4 or
Smad5+Smad4 is sufficient to induce BRE-luc
activity in C2C12 cells. Smad4 alone does not
influence inducibility by BMP6 (100 ng/ml).
(E) Binding of Smad4 to the BRE sequence is
critical for the reporter response to ligand-
dependent and ligand-independent Smad1 or
Smad5 overexpression. In the presence of the
Smad4-D4 DNA-binding mutant (harboring the
K81R and R88K mutations), neither Smad1 nor
Smad5 are able to drive BRE-luc expression in
MDA-MB468 cells. Expression of wild-type
Smad4 is sufficient to restore reporter
inducibility either in response to BMP6 or to co-
expressed Smad1 or Smad5. (F) In HepG2 cells, constitutively active (ca) type I receptors caALK1, caALK2, caALK3 and caALK6 specifically
induce BRE-luc reporter activity, while caALK4 or caALK5, do not. (G) Specific modulation of the BRE-luc reporter in response to activati n
or inhibition of BMP signaling in ES cells. 10 ng/ml of BMP4 and caALK3 induce while Smad7 blocks basal and BMP induced reporter
activity in transient assays. As expected, the 2C2P2C-luc reporter showed no response to modulation. **P<0.005; *P<0.05; #P<0.1.
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BMP4, or caALK3, highlighting the need for the presence of
the SBE-binding sites and indicated that the BRE element is
specifically activated by the BMP-signaling pathway. These
results showed that the complete BMP signal transduction
machinery, including type I and type II receptors and R-
Smads, was present in undifferentiated ES cells, as described
(Roelen et al., 1997; Wiles and Johansson, 1999; Ying et al.,
2003).
Generation of Smad1/5 reporter embryonic stem (ES)
cell lines
We used the BRE reporter coupled to β-galactosidase or
luciferase (Fig. 2A) to generate stable mouse ES reporter cell
lines. Because the BMP signal transduction machinery are
present in ES cells (Ying et al., 2003), we could screen for the
reporter lines most sensitive to activation by BMP. Transgenic
lines showing a 2-4-fold activation of the reporter in response
to 5 ng/ml of BMP4 (compared with the unstimulated controls)
were selected for further analysis. Using this criterion we
selected two ES reporter lines coupled to β-galactosidase
(BRE-lac1 and BRE-lac2) and one reporter line coupled to
luciferase (BRE-luc) for further study (Fig. 2A). Addition of
20 ng/ml of BMP4 markedly increases reporter activity
compared with unstimulated cells (Fig. 2B,C). Surprisingly,
not all cells expressed β-galactosidase upon stimulation by
BMP4 and further increase in ligand concentration did not lead
to uniform expression of β-galactosidase in the cultured cells,
although the reporter activity was increased (see below).
Southern blot analysis showed that the number of copies of the
construct integrated for the selected lines was less than 10
(results not shown).
Response of Smad 1/5 ES reporter cell lines to BMP is
dose dependent
We investigated whether the response of the Smad1/5 reporter
lines BRE-lac1, BRE-lac2 and BRE-luc to BMP was dose
dependent. BMP4 was added in the range of 1 to 100 ng/ml,
and reporter activity measured in whole cell lysates. All three
Smad 1/5 reporter cell lines showed similar dose-dependent
reporter activation upon BMP stimulation (Fig. 2D-F).
Addition of 5 ng/ml of BMP4 to the reporter ES cells resulted
in a 3- to 4-fold induction of the reporter, while at higher
concentrations of BMP4 (e.g. 20 ng/ml), BRE-lac1 and BRE-
lac2 reporter ES cells showed greater fold induction (7- to 8-
fold) than BRE-luc ES cells (6-fold). We then investigated
whether the reporter activity could be correlated with
upregulation of Id1, a target of BMP in ES cells (Hollnagel et
al., 1999; Korchynskyi and ten Dijke, 2002). Western blot
analysis for Id1 in BRE-lac1 and BRE-lac2 whole cell extracts
showed that Id1 protein levels increased in a dose-dependent
manner (Fig. 2G) consistent with the measured reporter
activity. In accordance, the increase in reporter activity was
also accompanied by a dose-dependent increase in
phosphorylation of Smad1/5/8 proteins (Fig. 2H). These
experiments showed that there is a close correlation between
different readouts of active BMP signaling (phosphorylation of
Smad1/5/8, levels of Id1 protein) and reporter activity in
Smad1/5 ES reporter lines.
Fig. 2.Response of stable ES
reporter cell lines to BMP4.
(A) Constructs used to generate
transgenic ES cells. BRE-β-
galactosidase or BRE-luc
reporter constructs and a PGK-
hygromycin cassette were co-
electroporated in wild-type ES
cells. Single colonies were
picked from selection medium
(150 µg/ml hygromicin) and
genotyped by PCR on genomic
DNA. Transgenic ES cell lines
were assayed for BMP-induced
reporter expression. Basal
reporter activity was observed in
(B) unstimulated BRE-lac1 ES
cells. (C) Reporter activity
increased in response to 20
ng/ml BMP4. Bars, 50 µm
(B,C). Activity of the reporter
gene in ES lines BRE-lac1 (D),
BRE-lac2 (E) and BRE-luc (F)
increases with increasing
concentrations of BMP4.
Western blots for Id1 (anti-Id1
antibody) (G) and for activated
Smad1/5/8 (PSmad1/5/8, PS1
antibody) (H) were performed on the same extracts as in D and E; expression profile of these proteins show good correlation with the reporter
activity. Note that the middle band in the triplet corresponds to phosphorylated Smad1/5/8 (black arrowheads). 10 µg/ml of protein was loaded
in each lane and confirmed by Ponceau S staining. Nonspecific bands are shown as loading control (l.c.). The results are represented as th
mean of three independent experiments (mean±s.d.).
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ES cells express and respond to stimulation by BMPs in
vitro
Basal levels of reporter activity were observed in unstimulated
transgenic ES cells. Since R1 ES cells are known to express at
least BMP4 (Gratsch and O’Shea, 2002; Johansson and Wiles,
1995), we investigated whether BMPs expressed in IB10 ES
cells could account for these basal levels of reporter activity.
Transcripts for BMP4 and BMP7, but not BMP2, were detected
by RT-PCR on cDNA from wild-type IB10 (WT) and
transgenic ES lines BRE-lac1, BRE-lac2 and BRE-luc (Fig.
3A). Furthermore, medium conditioned in WT ES cells for 24
hours transactivated BRE-luc in transiently transfected HepG2
cells, while unconditioned medium not exposed to ES cells did
not (Fig. 3B). This suggested that the basal levels of reporter
activity (Fig. 2B,D,E,F) were not due to nonspecific signals nor
to BMPs in basal ES cell culture medium, but to BMPs (most
likely BMP4 and BMP7) produced by the ES cells.
Noggin is an extracellular inhibitor of BMP signaling
(Zimmerman et al., 1996). Noggin molecules bind directly to
BMPs, preventing subsequent binding to their cognate
receptors (Groppe et al., 2002). Addition of increasing amounts
of noggin to BRE-luc ES cells markedly decreased basal
reporter activity (Fig. 4A), which together with the observation
that medium conditioned in ES cells activated the BRE-luc
reporter in HepG2 cells, showed that active BMPs are present
in the conditioned medium. In similar experiments on BRE-
lac2 and BRE-lac1 ES cells, noggin blocked both basal and
reporter activity induced by 5 ng/ml of BMP4 (Fig. 4B and
results not shown). While 10 ng/ml of BMP4 could partially
rescue the inhibitory effect of 10 ng/ml of noggin, the highest
concentration of noggin, 100 ng/ml, strongly inhibited both the
basal and the reporter activity induced by BMP4. Increasing
the concentration of BMP4 to 50 ng/ml was sufficient to
overcome the inhibitory effect of 100 ng/ml of noggin. This
showed that BMP4 can rescue the inhibitory effect of noggin
in a dose-dependent fashion. As expected, western blot
analysis of Id1 on BRE-lac2 whole cell lysates showed strong
correlation between the induction of Id1 by BMP and the
reporter activity (Fig. 4C): levels of Id1 decreased in response
o increased inhibition of BMP signaling by noggin while
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Fig. 3.ES cells express active BMP4 and 7 but not BMP2. (A) RT-
PCR on cDNA from wild type and transgenic ES cell lines BRE-luc,
BRE-lac1 and BRE-lac2. All the lines tested express BMP4 and
BMP7, but not BMP2. Using the same primer sets, transcripts for
BMP2, 4 and 7 were detected by RT-PCR on cDNA from E9.5
mouse hearts, as expected (results not shown). β-actin was a positive
control for the reverse transcription reaction; expression of Oct4
indicates the undifferentiated state of the ES cells.
(B) Transactivation assay in HepG2 cells. Medium conditioned by
ES cells induces BRE-luc reporter activity in HepG2 cells. Non-
conditioned medium had no effect. As a positive control, 10 ng/ml
BMP4 was added to transfected cells to activate the BRE-luc
reporter. As a negative control, HepG2 cells were transfected with
the BRE-luc reporter and no BMP was added. Results are presented
as mean fold induction (±s.d.) of triplicates in relation to
unstimulated cells, set to 1 (*P<0.05).
Fig. 4.Autocrine BMP pathway in ES cells. Noggin and BMP were
added to reporter ES cell lines (A) BRE-luc and (B) BRE-lac2 at
different concentrations to assess the reporter activity in response to
activation/inhibition in vitro. The same results were obtained in
BRE-lac1 ES cells (results not shown). (C) Id1 protein levels in a
western blot correlated with the reporter activity in BRE-lac2 protein
extracts. Equal amounts of protein (10 µg) were loaded in each lane
and confirmed with Ponceau S staining; nonspecific bands are shown
as loading control (l.c.). Results are presented as the mean of
triplicate experiments (mean±s.d.).
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increasing amounts of BMPs also increased the levels if Id1
protein. Similar results were obtained with BRE-lac1 ES cells
(results not shown). These results suggested that the reporter
genes in the generated transgenic lines reflect activation and
inhibition of the BMP signaling pathway similarly to the
endogenous target Id1 in ES cells.
Differentiation potential of the ES reporter lines
Because the Smad1/5 ES reporter lines generated expressed the
stem cell marker Oct4 (Fig. 3A), they were likely to be
pluripotent and able to participate in the development of an
embryo. However, to determine whether they had retained
pluripotency, BRE-lac1, BRE-lac2 and BRE-luc ES cells were
injected in the testis capsule of syngenic mice (129 OLA). All
three ES reporter lines gave rise to teratomas, which are tumors
composed of well-differentiated tissues from endodermal,
mesodermal and ectodermal origin (Stevens, 1967).
Morphological analysis of 4-week-old teratomas derived from
line BRE-lac1 showed differentiated tissues, such as
epithelium, bone, striated muscle, adipose tissue and cartilage
(Fig. 5B-D), similarly to teratomas derived from BRE-lac2 and
BRE-luc reporter lines (results not shown). When stained for
β-galactosidase activity, areas of cartilage in the teratomas
showed strong blue staining (Fig. 5D), which correlated with
the expression of Smads 1 and 5 in chondrocytes of E15
embryos (Flanders et al., 2001) and indicated that BMP
signaling is active in developing cartilage within the teratoma.
These experiments showed that the reporter ES cells retained
pluripotency and that differentiated derivatives of the BRE-
lac1 ES cell line responded to endogenous signaling.
Transient chimeric embryos show reporter expression at
sites of BMP expression
To establish whether the reporter lines would be able to
respond to the effective levels of Smad-dependent BMP
signaling in mouse embryos, we injected BRE-lac1 ES cells
into blastocysts expressing GFP ubiquitously (Hadjantonakis
et al., 1998). When injected into the inner cell mass, the
reporter ES cells contribute to the formation of the embryo
proper (Nagy et al., 1993). Transient chimeric embryos were
isolated at E9.5 and stained for β-galactosidase activity.
Virtually uniform green fluorescence suggested that the degree
of chimerism was low and mosaic (results not shown).
However, 3 of 10 embryos showed prominent β-galactosidase
staining in the heart, the optic vesicle, somewhat weaker
staining in the ventral limb bud and scattered cells in the first
and second branchial arches (Fig. 6A). At E9.5, BMP2, 4, 5,
6, 7 and 10 are expressed in the heart (Schneider et al., 2003)
and BMP4, BMP2 and BMP7 in the optic vesicle (Dudley et
al., 1995; Furuta and Hogan, 1998; Lyons et al., 1995;
Wawersik et al., 1999). In the forelimb bud, both BMP2 and
BMP7 are expressed in the apical ectodermal ridge (AER) and
in the limb mesenchyme (Lyons et al., 1995). Interestingly, in
the forelimb bud, reporter activity appears restricted to the
ventral mesenchyme (Fig. 6A). Transverse sections through the
heart of chimeric embryos showed β-galactosidase staining in
the myocardial layer of the outflow tract (OT), bulbus cordis
(BC) and ventricle, as well as in the myocardium surrounding
the atrio-ventricular canal (AVC, Fig. 6D,E). Low β-
galactosidase staining was found in the endocardium. Thus, the
sites of expression of the transgene correlated clearly with sites
where BMPs are known to be expressed.
Smad 1/5 transcriptional activity in transgenic E9.5
embryos
The Smad 1/5 ES reporter lines were injected into C57BL/6
blastocysts and the resulting male chimeras were crossed with
wild-type C57BL/6 or C57BL/6xCBA females for germline
transmission of the reporter. First generation transgenic males
were crossed with wild-type C57BL/6xCBA females and their
progeny analyzed at E9.5. For simplicity, transgenic embryos
derived from the BRE-lac1 or BRE-lac2 ES reporter lines are
referred to as BRE-lac1 and BRE-lac2 embryos, respectively.
While the pattern of β-galactosidase expression in
heterozygous BRE-lac1 or BRE-lac2 embryos was similar
to that in chimeric embryos, other sites also stained. β-
Galactosidase reporter expression was found in the roof of
the neuroepithelium of the midbrain (Fig. 6B,C, green
arrowheads). In the hindbrain, expression is absent in the
region of rhombomere 5 (Fig. 6C; see inset). Reporter
xpression was further detected in the first and second
branchial arches, in the ventral forelimb bud and in the ventral
posterior mesenchyme (Fig. 6B,C and results not shown). β-
Galactosidase was observed in the dorsal optic vesicle, while
low expression was detected in the overlying ectoderm (Fig.
6F). Phosphorylated Smad1/5/8 immunostaining in the dorsal
Fig. 5.Teratomas derived from reporter ES cells in adult male mice.
At 4 weeks, ES cells injected in the testis capsule of syngenic mice
(129 OLA) give rise to different tissues. Compare the normal testis
tissue in A with a representative sample of ES-derived tissues in B, C
and D. Bone (b), cartilage (ca), striated muscle (s), adipose tissue (a)
and epithelial tissue (ep, red arrow) were found (B,C). β-
Galactosidase staining of BRE-lac1-derived teratomas showed
staining in areas of cartilage and perichondrium (D, black
arrowhead). Note that not all the chondrocytes show β-galactosidase
staining, suggesting regional differences in activation of Smad1/5
signaling in chondrocytes. Sections (7 µm) were stained either with
Eosin/Hematoxilin (A-C) or Neutral Red and β-galactosidase (D).
Abbreviations: it, interstitial tissue; sp, spermatidia. Bar, 100 µm. 
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optic vesicle, dorsal neural tube and ventral limb bud
mesenchyme in E9.75 embryos has been reported (Ahn et al.,
2001), which is consistent with the β-galactosidase staining
found in the BRE-lac1 and BRE-lac2 embryos.
Although expressed essentially at the same sites, BRE-lac2
embryos at E9.5 showed an overall stronger expression of the β-
galactosidase reporter (Fig. 6C) compared with BRE-lac1
embryos (Fig. 6B). Strong β-galactosidase staining was observed
in the aorta of BRE-lac2 but not in BRE-lac1 embryos. In
embryos of both transgenic lines, strong β- alactosidase staining
was found in the OT, bulbus cordis, AVC and in the common
atrial chamber and ventricle, although not uniformly (Fig. 6G,H).
Expression of β-galactosidase was found in endocardium and in
the pericardium (Fig. 6G,H). In BRE-lac1 embryos, the reporter
expression in the endocardium and pericardium is sparser,
suggesting that the sensitivity to Smad1/5 transcriptional activity
in these embryos was less than in BRE-lac2 embryos (results not
shown). The results obtained indicate that activation of target
genes by Smad1/5 proteins is important for heart development.
In agreement, we found expression of the β-galactosidase
reporter in the cardiac crescent in E7.5 and overall in the heart in
E8.5 embryos (Fig. 6I,J and results not shown).
We next asked whether the β-galactosidase reporter
expression coincided with phosphorylated Smad1/5/8 in the
nucleus. Immunostaining with an antibody against PSmad1/5/8
(PS1) was performed in E9.5 embryos, following β-
galactosidase staining (Fig. 6K-N). The results showed that in
the tissues examined, most of the PSmad1/5/8 positive cells also
stained for β-galactosidase (approximately 80%) with 8-12% of
cells only staining for β-galactosidase and 8-13% stained only
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Fig. 6.Analysis of reporter expression in
transgenic E9.5 embryos. (A) Chimeric
embryos were generated with the BRE-lac1
ES cell line by injection into blastocysts of
β-actin-GFP mice and analyzed at E9.5. β-
galactosidase staining was present in the
heart, the optic vesicle (op), the ventral
forelimb (l), neural crest (nc, blue
arrowhead) and in the branchial arches (ba).
Adult male chimeras generated with BRE-
lac1 and BRE-lac2 ES lines were crossed
with wild-type females and the progeny
analyzed at E9.5. BRE-lac1 (B) and BRE-
lac2 (C) transgenic embryos showed reporter
expression pattern similar to that in transient
chimeras. β-Galactosidase staining was also
detectable in the roof of the midbrain
neuroepithelium (green arrowheads), in the
hindbrain, where the region around
rhombomere 5 showed very low β-
Galactosidase staining, in the posterior
mesenchyme and in the aorta (white arrows).
(D-E) Transversal sections through the heart
of the embryo shown in A. β-Galactosidase
staining is found in the outflow tract (ot), the
bulbus cordis (bc) and the ventricle (v), as
well as in the atrioventricular canal (avc, red
arrowhead). (F) In the optic vesicle, reporter
expression is restricted to the dorsal side,
while low expression was observed in the
overlying ectoderm. (G,H) Transverse
sections through the heart of BRE-lac2
transgenic embryos showed reporter
expression in endocardium, pericardium and
myocardium, with stronger expression in the
outflow tract and the atrioventricular canal.
Frontal (I) and lateral (J) views of a
transgenic embryo showing β-galactosidase
expression in the cardiac crescent and in the
amnion at E7.5. (K-N) Co-staining for
phosphorylated Smad1/5/8 (PS1 antibody)
and β-galactosidase in E9.5 transgenic embryos. β-Galactosidase expression coincides with PS1 staining in the heart and in the foregut (K,L),
while in the neural tube and neural crest some cells are stained for PS1 and not β-galactosidase (M, black arrowheads). High correlation
between phosphorylated Smad1/5/8 and β-galactosidase was observed in the branchyal arches (N). (O) Quantification of the incidence of β-
galactosidase and PS1 staining. Sections containing posterior body wall (pbw), heart and foregut (h+f), neurectoderm (nt) and branchyal arches
(ba) were scored for double or single β-galactosidase and PS1 staining. Results are presented as the mean of the percentage of single or double
stained versus total of stained cells within three sections per count. Bars, 500 µm (A-C,I-J) and 100 µm (D-H,K-N). Abbreviations: a, atrium;
am, amnion; as, aortic sac; cc, cardiac crescent; f, foregut; l, forelimb bud; p, pericardium; r5, rhombomere 5.
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with PS1 (Fig. 6O). Exceptionally, in the neural tube and in
migrating neural crest cells an enhanced proportion of cells
stained with PS1 only (approximately 66%, see Fig. 6M, black
arrowhead and 6O, nt). This probably reflects the kinetic
differences in each readout of BMP. Phosphorylation of
Smad1/5/8 is rapid and transient while β-galactosidase detection
is relatively delayed and sustained, indicated the cells that have
activated a transcriptional response earlier but may no longer be
receiving an activating signal. Furthermore, the presence of co-
repressors in the nucleus might prevent transcription of target
genes by activated Smad1/5/8 (Zwijsen et al., 2003).
Discussion
BMPs are known to play roles in many aspects of embryonic
patterning and development (Hogan, 1996). Several
components of the BMP pathway members have been deleted
in mice (reviewed in Chang et al., 2002; Goumans and
Mummery, 2000) and this has yielded important information on
the functions of the BMP signaling early in development. BMPs
are secreted molecules and can therefore reach sites distant from
the source (Dosch et al., 1997). In addition, BMPs are sensitive
to the presence of specific secreted inhibitors, such as noggin
and chordin, that contribute to establish gradients of BMP
signaling in the developing embryo (Balemans and Van Hul,
2002). Therefore, the question of where and when active BMP
signaling takes place during development is very important to
understanding the functional relevance of this signaling
pathway. Development of a phospho-specific antibody capable
of recognizing the activated forms of Smad1/5/8, but not Smad2
or Smad3 (Persson et al., 1998) has been pivotal towards
understanding BMP signaling activation in vitro and in vivo.
However, the presence of phosphorylated Smads (1, 5 or 8) in
the nucleus is not necessarily equivalent to BMP-induced
transcriptional activity. Recent studies have shown that Smad6
can recruit CtBP in the nucleus and repress Smad1-induced
transcription (Lin et al., 2003). An alternative approach to study
Smad1/5 transcriptional activity is to isolate enhancer elements
from the promoters of BMP target genes and use these to drive
reporter gene expression in cells in vitro and in embryos in vivo.
We have generated transgenic ES cell lines that express a
reporter gene (β-galactosidase or luciferase) under the control
of a BMP-responsive element (Korchynskyi and ten Dijke,
2002), which we showed is specifically activated by Smad1/4
and Smad5/4 (and to a lesser extent, by Smad8/4) complexes
and to respond to BMPs. In BRE-lac1 and BRE-lac2 ES cells
in vitro, we have observed that β-galactosidase was not
expressed in all the cells in culture upon stimulation with high
concentration of BMP4. Upon single cell re-cloning,
approximately 20 subclones of the BRE-lac1 and BRE-lac2 ES
reporter lines were evaluated for responsiveness to BMP4 (100
ng/ml). No significant increase in the proportion of cells
expressing β-galactosidase was observed (results not shown),
suggesting that transgene inactivation occurs in vitro. Random
inactivation of transgenic β-galactosidase-containing constructs
by methylation in P19 embryonal carcinoma (EC) cells has
been reported (McBurney et al., 2002). We do not know
whether this is involved in the in vitro observations described,
but germline transmission in transgenic mice generated from
the ES reporter lines (BRE-lac1, BRE-lac2 and BRE-luc)
ensures that the whole animal is derived from a single ES cell
genome. In addition, we have shown that β-galactosidase
expression was found in the same tissues in transgenic embryos
derived from two independent integration events in ES cells
(BRE-lac1 and BRE-lac2 ES reporter lines). Moreover,
β-galactosidase expression generally coincided with
phosphorylated Smad1/5/8 and with known sites of BMP
expression in vivo, indicating the transgenic Smad1/5 mice are
efficiently reporting in vivo transcriptional activity of Smad1/4
and Smad5/4 complexes, making it unlikely that silencing of
the β-galactosidase transgene takes place in vivo.
An autocrine BMP pathway in ES cells
The BMP antagonists chordin and noggin induce
differentiation of ES cells into neural lineages (Gratsch and
O’Shea, 2002). Accordingly, BMP promotes differentiation of
ES cells into non-neural fates (Johansson and Wiles, 1995;
Wiles and Johansson, 1999). It was, therefore, intriguing that
undifferentiated ES cells expressed BMP4 and BMP7.
Interestingly, a recent report has shown that Smad-dependent
BMP signaling induces Id1, which together with LIF is
sufficient to maintain self-renewal of ES cells in culture (Ying
et al., 2003). We have confirmed the existence of this BMP
autocrine pathway and the induction of Id1 by studying the
response of transgenic Smad1/5 reporter ES cells to BMPs.
Endogenous BMP7 can also contribute to the maintenance of
the undifferentiated state in these cells.
Smad1/5 ES cell lines give rise to teratomas and
respond to endogenous signalling
BMPs play an important role in the differentiation of
chondrocytes (Kramer et al., 2000) and further differentiation
of hypertrophic chondrocytes into bone (Hogan, 1996; Minina
et al., 2001). It was therefore of interest that ES-cell-derived
cartilage tissue in teratomas showed β-galactosidase staining.
Strikingly, we found that patches of chondrocytes, not the whole
cartilage tissue, expressed β-galactosidase in the generated
teratomas. This suggested that not all chondrocytes responded
equally to BMPs. In agreement, immunohistochemical staining
for Smad1 and Smad5 has shown a mix of nuclear and
cytoplasmic staining in the chondrocytic population (Flanders
et al., 2001), indicating that not all chondrocytes respond to
BMP signals simultaneously or that inhibition of BMP
signaling takes place in part of the chondrocyte population. It
has been shown that osteoblastic differentiation induced by
BMP signaling can be inhibited by extracellular-signal-
regulated kinases (ERK) by phosphorylation of Smad1 in
specific sites in the linker domain (Nakayama et al., 2003).
Endogenous Smad1/5 signaling in transgenic BRE-lac1
and BRE-lac2 mice
In mice, phosphorylated Smad1/5/8 has been shown in the
dorsal optic vesicle, dorsal hindbrain and limb bud mesoderm
and ectoderm (Ahn et al., 2001). In Xenopusas well as in chick,
similar studies have shown that phosphorylated Smad1/5/8
protein is found, among other sites, in neural crest, in the dorsal
optic vesicle and in the heart, including myocardium and
endocardium (Faure et al., 2002; Kurata et al., 2001). β-
Galactosidase staining in BRE-lac1 and BRE-lac2 E9.5
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embryos showed a high correlation with these findings,
supporting the idea that developmental mechanisms are
evolutionarily conserved.
β-Galactosidase expression was found to be asymmetrical in
the heart of E9.5 Smad1/5 reporter mice. Except for BMP6,
which is expressed ubiquitously in the heart, expression of
other BMPs, such as BMP4, 5 and 7, is restricted to myocardial
cells, while BMP10 is specifically expressed in trabeculae
(Chen et al., 2004; Delot, 2003). This suggests that expression
of BMP ligands alone is not sufficient to explain regulation of
the transcriptional activity of Smad1/5 in the heart and
underlines the importance of the Smad1/5 reporter mice for the
study of active Smad1/5 induced transcription in development.
Conditional deletion of ALK3 in cardiomyocytes has
highlighted the potential of paracrine BMP signaling in heart
development (Gaussin et al., 2002). The fact that we observe
reporter activity in myocardium, but also in endocardium and
pericardium supports the idea that paracrine BMP signaling
takes place in the heart. In addition, the staining found both in
the OT and in the AVC is consistent with a pivotal role of
BMPs in cardiac septation (Delot et al., 2003; Jiao et al., 2003).
In summary, we have generated reporter mice for monitoring
active transcription of Smad1/Smad4 and/or Smad5/Smad4-
dependent target genes in vivo. This reporter system allows,
for the first time, an in vivo readout of the spatio-temporal
activation of Smad1/Smad5 target genes in mice. The
usefulness of these mice has been recently demonstrated in a
study on the role of ALK2-mediated BMP signaling in the
allocation of PGCs (Chuva de Sousa Lopes et al., 2004).
Further studies describing the pattern of Smad1/5-mediated
transcriptional activity at different stages of mouse
development will allow us to elucidate their role in other
developmental processes in the mouse.
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